Health Innovation Summit 2023

Tiffany A. Albert is senior vice president of Health Plan Business for Blue Cross Blue Shield of Michigan (BCBSM) with oversight for new group sales, specialty benefits, account management, distribution channel partnerships and sales operations. Most recently, Albert was president and chief executive officer of Blue Care Network of Michigan (BCN) and a vice president at BCBSM. As the leader of Michigan’s largest health maintenance organization (HMO), Albert provided direction, leadership and management of the operations of BCN and was responsible for driving strategy and execution that optimized HMO performance across all business segments. Prior to BCN, Albert was president and CEO of LifeSecure Insurance Company, a national Blue Cross subsidiary headquartered in Brighton, MI. Albert maintains an accident and health insurance agent license in the State of Michigan and her unique experience in the insurance industry spans more than 25 years. Starting her career in information technology and operations for an independent preferred provider organization led Albert to several leadership and executive positions. Prior to joining Blue Cross in 2010, she served as vice president of Corporate Sales and Provider Services, vice president of National Accounts, and senior vice president of Account Management for a subsidiary of a large national carrier. Her broad background includes new business development, customer management and retention, marketing, program development and implementation, operations, provider contracting, information technology and distribution channel management.

Bio coming soon!

Deirdre Baggot is a partner in the health and life sciences practice at Oliver Wyman. She will play an important role in helping the Provider team expand its footprint further into Provider Systems, Clinical Domains, Value-Based Care/Contracting, and Government Programs. Baggot spent ten years in academic healthcare, first at Northwestern Memorial Hospital and later at the University of Michigan Health System. She shifted to consulting in 2010 by joining GE/Camden as Senior Vice President and then joining ECG as a Partner. Baggot also worked for CMS as an Expert Reviewer for the Bundled Payments for Care Improvement Initiative, and advised NY Medicaid on the development of eight chronic disease bundles. Most recently, Baggot has been working with Verily start-up, Onduo, on new payment models for diabetics. She holds a PhD from University of Colorado, an MBA from Loyola University Graduate School of Business, and obtained her BS in Nursing from Southern Illinois University. She also holds a Certificate in Healthcare Executive Leadership from the Wharton School. Baggot and her husband, Ted, have two children, Harry and Emily, and spend most weekends at their kids’ sporting events. They also enjoy traveling, snowboarding in Beaver Creek, and watching Michigan football. People would be surprised to know that Deirdre has 10 siblings!

Bio coming soon!

Sunil Budhrani, MD is the Chief Innovation and Medical Officer at Capital Rx, where he is responsible for innovative clinical offerings and partnerships, expansion of JUDI® platform capabilities, enhanced pharmacy benefit management (PBM) and administration solutions, and continued success with membership growth. He is a Board-Certified Emergency Medicine Physician on the George Washington University School of Medicine faculty and has managed departments and practiced at several other leading institutions nationwide. Dr. Budhrani brings decades of experience as a physician executive to Capital Rx, having most recently served as the Chief Executive Officer of Innovation Health, a first-of-its-kind payer-provider partnership between CVS/Aetna and one of the largest health systems in the Washington DC Metropolitan Area, INOVA Health System. In addition to his roles in hospital settings, Dr. Budhrani also founded one of the first national end-to-end telemedicine solution companies, CareClix Telemedicine, and prior to that, a multi-sited, regional Urgent Care system, PrimeMed Urgent Care Systems. He also served as the first Chief Medical Officer of the Affordable Care Act health plan, Evergreen Health Care, for the State of Maryland. Dr. Budhrani graduated with Honors from the University of Pennsylvania. He then completed his Medical Degree and a Master of Public Health at George Washington University, where he was a 2021 recipient of the School’s Distinguished Alumni Award for his exemplary service during the pandemic. He completed his residency training in Emergency Medicine at the Tufts University School of Medicine in Massachusetts and his MBA at the University of Baltimore.

Dr. Austin Chiang is the first Chief Medical Officer for the gastrointestinal business of Medtronic, the global leader in health technology. He also continues to practice as an interventional gastroenterologist at an academic center in Philadelphia. He completed his undergraduate studies at Duke University before earning his MD at Columbia University. He stayed for Internal Medicine residency at New York Presbyterian Hospital and completed his GI and bariatric endoscopy fellowships at Brigham and Women's Hospital. He obtained his MPH from the Harvard TH Chan School of Public Health before completing an advanced endoscopy fellowship at Jefferson Health. Passionate about empowering patients with accurate medical information online, he is one of the most influential voices in the field of gastroenterology across multiple social media platforms including Instagram, Twitter, TikTok, and YouTube with over 500,000 followers and over 130 million views. Chiang has conducted extensive research in social media and is champion of physician presence on social media and is the Chief Medical Social Media Officer of Jefferson Health and Founding President of the Association for Healthcare Social Media (AHSM, @ahsm_org), the first 501(c)(3) professional society for health professional social media use. He has worked closely with all major national GI societies on social media efforts and was 2018’s Healio Gastroenterology Disruptive Innovator of the Year, The Philadelphia Inquirer’s 2019 Influencers of Healthcare Rookie of the Year, and among 2019 Medscape Top 20 Social Media Physicians, and a 2021 GLAAD Media Award Nominee. He spoke at South by Southwest (SXSW) 2021, and his role in social media has been featured by The New York Times, CNBC, and BBC News. He sits on the inaugural YouTube Health Advisory Board and in 2022, joined the White House Healthcare Leaders in Social Media Roundtable.

Bio coming soon!

Bio coming soon

Nicholas L. Coussoule is Senior Vice President, Enterprise Business and Technology Solutions at Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ). He joined Horizon BCBSNJ in this role in February 2021, and has responsibilities for the Information Technology, Information Security and Analytics divisions. Coussoule was previously Senior Vice President, Chief Information and Strategic Technology Officer of BlueCross BlueShield of Tennessee, where he led the Information Technology, Information Security and Business Engineering functions. He began his career in consulting with the Geary Corporation in the U.S. and internationally, and has held Chief Information Officer roles in multiple companies across several industries. Coussoule was also a member and former Chairman of the National Committee of Vital and Health Statistics, the primary federal advisory committee to the Secretary of Health and Human Services on health data, statistics, privacy, national health information policy and the Health Insurance Portability and Accountability Act (HIPAA). He was appointed by the HHS Secretary to a four-year term in 2015, reappointed to a second four-year term in 2019 and appointed to committee chair in 2020 until 2022. Coussoule holds a Bachelor’s degree with honors in Economics and Mathematics from Dartmouth College, and is a 2015 graduate of the Nashville Health Care Council Fellows program.

Joseph DeRisi, PhD, is Co-President of the Chan Zuckerberg Biohub and a Professor in the Department of Biochemistry and Biophysics at UCSF. He employs an interdisciplinary approach combining genomics, bioinformatics, biochemistry, and bioengineering to study parasitic and viral infectious diseases in a wide range of organisms, for the purpose of discovering and studying novel or unrecognized biothreats. Early work in his lab contributed to the identification of the SARS coronavirus in 2003. In a parallel effort, DeRisi studies P. falciparum, the causative agent of the most deadly form of human malaria, in order to develop faster, better therapeutic options. DeRisi was one of the early pioneers of DNA microarray technology and whole genome expression profiling and is nationally recognized for his efforts to make this technology accessible and freely available. In 2004, he was chosen for a MacArthur Fellowship. In addition to being a Searle Scholar and a Packard Fellow, DeRisi has received the Heinz Award in Technology, the Economy and Employment, and was named an Eli Lilly and Company Research Award Laureate. He was elected to the American Academy of Arts and Sciences in 2015, and the National Academy of Sciences in 2016, and the National Academy of Medicine in 2017. He received a B.A. in Biochemistry and Molecular Biology (1992) from the University of California, Santa Cruz, and a Ph.D. in Biochemistry (1999) from Stanford University prior to joining the UCSF faculty as a Sandler Fellow in 1999. DeRisi was a Howard Hughes Medical Investigator from 2006-2016, which he left to take on the role of Co-President of the Chan Zuckerberg Biohub, a non-profit medical research organization affiliated with UCSF, UC Berkeley, and Stanford University. DeRisi is continuing to pursue efforts toward data-driven diagnostics for infectious disease, and recently, autoimmune disorders as well.

Gabe Diop is the Co-founder of Path Mental Health, a healthcare provider group enabled by technology. He oversees clinical and partnerships with payers and health systems. Path’s mission is to make mental healthcare work for everyone. He’s passionate about bringing access, equity, quality, and a modern consumer experience to over 100m members that Path covers today. Previously he led partnerships at Spruce Health, a telehealth company that powered the onsite clinic communication for a few Fortune 500 companies. He comes from a family of doctors and graduated with a Bachelor of Arts degree in economics from Harvard.

Jesse M. Ehrenfeld, MD, MPH, was elected president-elect of the American Medical Association in June 2022. He is a senior associate dean, tenured professor of anesthesiology and director of the “Advancing a Healthier Wisconsin Endowment” at the Medical College of Wisconsin. He was elected to the American Medical Association Board of Trustees in 2014. Dr. Ehrenfeld divides his time among clinical practice, teaching, research and directing a $560-million statewide health philanthropy. He also has an appointment as an adjunct professor of anesthesiology and health policy at Vanderbilt University in Nashville, Tenn., and as an adjunct professor of surgery at the Uniformed Services University of the Health Sciences in Bethesda, Md. Dr. Ehrenfeld is a consultant to the World Health Organization Digital Health Technical Advisory Group and previously served as co-chair of the Navy Surgeon General’s Taskforce on Personalized and Digital Medicine and as a special advisor to the 20th U.S. Surgeon General. In addition to his work with the AMA, Dr. Ehrenfeld has served on the governing boards of the American Society of Anesthesiologists Resident Component, the Massachusetts Medical Society and the Illinois State Medical Society. He also served as speaker of the house of delegates of the Massachusetts Medical Society for six years. Dr. Ehrenfeld’s research, which focuses on understanding how information technology can improve surgical safety and patient outcomes, has been funded by the National Institutes of Health (NIH), the Department of Defense, the Robert Wood Johnson Foundation, the Anesthesia Patient Safety Foundation, and the Foundation for Anesthesia Education and Research. He currently serves on the National Academy of Medicine’s Health Policy Fellowships and Leadership Programs Advisory Committee. His work has led to publication of more than 275 peer-reviewed manuscripts. He is editor-in-chief of the Journal of Medical Systems and has co-authored 22 clinical textbooks that have been translated into multiple languages. Dr. Ehrenfeld has received numerous awards for his research and is a recipient of several prestigious teaching awards. For the past two decades, Dr. Ehrenfeld has advocated on behalf of lesbian, gay, bisexual, transgender and queer (LGBTQ+) individuals. In 2018, in recognition of his outstanding research contributions, he received the inaugural Sexual and Gender Minority Research Investigator Award from the director of the NIH. Born in Wilmington, Del., Dr. Ehrenfeld is a graduate of Phillips Academy, Haverford College, the University of Chicago Pritzker School of Medicine and the Harvard School of Public Health. He completed an internship in internal medicine, a residency in anesthesiology and a research informatics fellowship at the Massachusetts General Hospital. Board-certified in both anesthesiology and clinical informatics, Dr. Ehrenfeld is a fellow of the American Society of Anesthesiologists and the American Medical Informatics Association. A combat veteran who deployed to Afghanistan during both Operation Enduring Freedom and Resolute Support Mission, Dr. Ehrenfeld, for his work in capturing and supporting the lives of LGBTQ+ people, was recognized in 2015 with a White House News Photographers Association award and, in 2016, with an Emmy nomination. Dr. Ehrenfeld and his husband, Judd Tabaco, have a son, Ethan.

Randy Falkenrath is Founder of Epiphany Solutions, LLC a specialty pharmacy consulting practice. Most recently, he served as President of the Onco360 Oncology Pharmacy, CareMed Specialty Pharmacy and ConnectMed360 patient hub services businesses in BrightSpring Health. Falkenrath has over four decades of healthcare experience (payor, PBM, pharma manufacturer, consulting) with primary focus on specialty pharmacy strategies for patient experience, clinical and cost management programs. Falkenrath previously served as Vice President of Specialty Pharmacy at Humana where he led strategy and program development for managing specialty conditions across the medical and pharmacy benefits. In addition, Falkenrath held the role of Senior Vice President of Specialty Pharmacy at both CVS Health and UnitedHealthcare following executive leadership positions at Computer Sciences Corporation (CSC), Baxter Healthcare and Searle Pharmaceuticals/Pfizer. Falkenrath holds an MBA from Northwestern University’s Kellogg School of Management and a B.S. in business from Northwestern University. Falkenrath is also a Vietnam-era veteran, having served four years in the U.S. Air Force where he was awarded an Air Force Commendation Medal from the Strategic Air Command.

Scott Frisch is the executive vice president and chief operating officer for AARP. He is responsible for all enterprise-wide operational and financial matters including human resources, information technology, real estate and facilities management as well as data and analytics performance management. Frisch has helped guide AARP through a period of dynamic change, reengineering the operational functions of the organization to maximize efficiencies and increase operating reserves. He established a $40 million investment fund that spurs innovation in health and wellness as well as a $60 million investment vehicle to accelerate research into cures for all types of dementia including Alzheimer’s. Frisch oversaw the comprehensive renovation of AARP’s 500,000 square foot national office headquarters in Washington, DC to provide the latest in technology and environmentally-friendly and innovative workspace. Prior to his appointment as COO, Frisch served as senior vice president and chief financial officer for AARP Services, Inc. (ASI), the for-profit subsidiary of AARP. He had previously served as chief financial officer and treasurer at AARP Financial, Inc. Prior to joining the AARP enterprise, Frisch held a variety of management positions at Columbia Management Group, NATIXIS Asset Management Services, Inc., Putnam Investments and KPMG. He graduated from Villanova University. He is a certified public accountant and previously held Financial Industry Regulatory Authority (FINRA) Series 6 and 63 licenses. Frisch is a Board member on the Greater Washington Board of Trade, Wish of a Lifetime from AARP, Older Adults Technology Services from AARP, the Downtown DC Business Improvement District Council and formerly served on the Board of Advisors of CBC Realty Investments. He sits on the Wall Street Journal CFO Network, the Executive Committee of the Milken Institute Center for the Future of Aging Business Council, the Social Impact Partners Global Consortium and is a Malcom Baldrige Executive Fellow and recipient of the 2021 Baldrige Foundation Award for Leadership Excellence in the Nonprofit Sector. Frisch is also a member of the DMV Regional Congress (previously served on the Connected DMV COVID-19 Strategic Renewal Task Force).

A citrus farmer by upbringing, economist by training, and high-tech entrepreneur by background, Sam Glick is a Partner at Oliver Wyman, where he leads the firm’s Health and Life Sciences business globally. Glick's clients include leading providers, health plans, biotech manufacturers, employers, enablement companies, retailers, and venture capital firms. He works collaboratively with their senior executive teams to create the infrastructure required to serve consumers successfully. Through support for activities ranging from organizational design to strategy development to operating model build and new product launch, Sam helps his clients create innovative solutions that provide delightful, affordable, high-quality care, coverage, and financing to consumers. Glick has been invited to speak at a number of events for healthcare senior executives and board members, including those sponsored by the American Hospital Association, The Conference Board, Consortium Health Plans, Health Evolution Summit, Integrated Healthcare Association, The Leadership Institute, and UnitedHealth Group. He has been published and quoted in publications such as the New York Times, the Wall Street Journal, The Economist, Harvard Business Review, CNN, and Bloomberg News, and has appeared on national television programs including NBC Nightly News. Previously, Glick was in the high-tech strategy practice at Accenture. Prior to that, he led strategy and corporate development activities at Mercer. He also spent six years as the founder and chief executive of Algebra Online, a web-based educational services business. Glick received his BA with honors in economics from Pomona College, and was a Rotary Ambassadorial Scholar and North American Postgraduate Scholar in the MSc program in economics at the University of Warwick. He chairs the Pomona College Board of Trustees, and serves as a member of the UCSF Rosenman Institute Advisory Board and the Meals on Wheels of San Francisco Honorary Board. Sam lives in San Francisco with his wife, Emily..

Bio coming soon!

With a background in aeronautics and a PhD in mechanical engineering, Martin Graf is a former rocket scientist. That training and experience made him an expert problem solver, and taught him how to communicate complex ideas to a broad audience - skills he uses every day as a Partner in Oliver Wyman's Health and Life Sciences (HLS) practice. Today, Graf works with health insurers and providers to improve their strategy and operations. He has 20 years of executive-level leadership and management consulting experience in healthcare and has worked with many of the largest players in the industry. He’s directly improved their businesses, and he focuses on driving major transformations. One of the most important moments in my career was delivering the largest project in the history of our practice - helping a major payer launch two new companies. That allowed us to demonstrate the scale we can operate at when we think big. Whether he’s designing rockets or creating a new health plan for a leading health system, Graf enjoys the challenges that come with tackling some of our country’s most complex problems. At Oliver Wyman, Graf is a member of the HLS management committee and co-leads the Government Healthcare platform. He is also the co-author of a graduate textbook on turbomachinery aerodynamics.

Bio coming soon!

Mark Hansberry is Senior Vice President, Chief Strategy and Marketing Officer for HealthPartners. Hansberry joined HealthPartners in 2016 and is responsible for strategically positioning and growing the organization by translating the needs and expectations of healthcare purchasers into innovative partnerships, products and business ventures the market will reward. He has experience working in some of the country's most progressive and competitive markets, creating differentiated value propositions for renowned healthcare institutions. By integrating insights of market trends and requirements with knowledge of care delivery and financing, Hansberry has led transformations the market rewards. Prior to joining HealthPartners, Hansberry served as a strategic advisor to several nationally respected health plans, health systems and healthcare start-up companies with a focus on positioning enterprises for success in the emerging value-based environment. Prior to consulting, Hansberry served as the Senior Vice President and Chief Strategy Officer for Fairview Health Services (Minneapolis, MN) for 14 years, Vice President of Business Development at Boston Children’s Hospital (Boston, MA) for 4 years, and Senior Director of Business Development at Advocate Health Care (Chicago, IL), for 8 years. Hansberry earned a bachelor of science from Boston College in Finance and Economics, and a master in business administration from University of Minnesota in Strategy and Marketing.

Bio coming soon!

Camille Harrison is Executive Vice President, Medicare and Chief Innovation and Experience Officer. In addition to overseeing the enterprise’s Medicare company, she is responsible for GuideWell Innovation and leads GuideWell and Florida Blue’s Customer Experience and Digital efforts. Harrison provides overall leadership for Florida Blue Medicare, including positioning and managing the performance of this business segment. She is leading the implementation of a new digital operating model which will enable at-scale digital transformation. Additionally, Harrison leads efforts to establish enterprise-wide metrics and analysis to better understand customer loyalty and develop a common approach for executing work across the organization. Within GuideWell Innovation, she plays a critical role in addressing important company challenges by identifying and delivering strategic, innovative solutions that help the enterprise better serve its members and communities. Harrison also co-leads the customer and community workstream of the Equity Alliance, an enterprise-wide initiative focused on addressing systemic racism and health disparities for Black Americans. She has held a series of progressively responsible roles since joining the enterprise in 2011. Prior to her current role, Harrison served as Senior Vice President and Chief Operating Officer for GuideWell Commercial Markets and GuideWell Innovation. She previously also held roles as Senior Vice President, Chief Customer Officer; Senior Vice President, Chief Customer Experience Officer; Group Vice President, Service and Business Process Management; and Chief of Staff to the Chairman and CEO. Before joining GuideWell and Florida Blue, Harrison was Chief of Staff to the Chairman and CEO at Blue Cross and Blue Shield of Minnesota. She also held a number of leadership positions at Horizon-Blue Cross Blue Shield of New Jersey. Harrison has more than 27 years of health care industry experience with a background in customer service, claims operations and general business operations, including government programs and client relations. She serves on the boards of Triple-S Management Corporation and WebTPA and represents Florida Blue as a corporate member of the Florida Blue Foundation, the United Way’s Tocqueville Society and the American Heart Association’s 2022 First Coast Executive Leadership Cabinet. She previously served as the Chair of the Florida Blue Foundation and on the board of GuideWell Source, The Early Learning Coalition of Duval County, Incepture and was Co-Chair of the 2018-2019 Go Red for Women Executive Leadership Cabinet. Harrison holds a Bachelor of Science degree in business education from Montclair State University in New Jersey and completed the Advanced Management Program from the University of Chicago Booth School of Business.

Marc Harrison, MD is a global healthcare leader, recognized for healthcare transformation and health equity advocacy. He is a pediatric critical care physician, and is the former president and CEO of Intermountain Healthcare. Dr. Harrison has joined the venture capital firm General Catalyst to launch and lead a new business with the mission to deliver health and wellness collaboratively, compassionately, and courageously – for all people. As president and CEO of Intermountain, Dr. Harrison led the organization to reimagine healthcare operations and champion innovation and collaboration to ensure that its 60,000 caregivers had access to the technology and tools to best reach, serve, and empower patients. In his first five years leading the organization, he executed a disciplined growth strategy with significant investments in telehealth and rural health to expand Intermountain’s service area from primarily Utah communities to serving patients throughout the Mountain West. Under his leadership, Intermountain embraced unconventional, public-private partnerships to confront some of the most pressing systemic challenges facing communities and industry to proactively keep people well and make communities healthier. Those initiatives were a catalyst for the national movement toward value-based care, advancing clinical education, and establishing a new Digital Hippocratic Oath ( developed by Graphite, a company co-founded by Intermountain) to improve hospital data interoperability and secure patient privacy rights. During his tenure, Intermountain partnered with more than 1,000 hospitals nationwide to launch Civica Rx, a nonprofit generic drug manufacturer and distributor, to make generic medications—including insulin, which they plan to offer in 2024—more accessible and affordable. Intermountain was a founding member of the Utah Alliance for the Determinants of Health, a collaboration of community partners proactively addressing forces that affect people’s ability to stay healthy. Additionally, Intermountain partnered with an international genomics leader and more than 100,000 volunteers to advance medical breakthroughs that will help prevent and treat genetic diseases for people around the globe. Before leading Intermountain, Dr. Harrison served as CEO of Cleveland Clinic Abu Dhabi, chief of international business development at Cleveland Clinic, and chief medical operations officer at Cleveland Clinic. Fortune recognized him as one of the Top 50 World’s Greatest Leaders in 2019, and Modern Healthcare has consistently recognized him among the Most Influential People in Healthcare. Dr. Harrison is the author of Possibility Unleashed: Pathbreaking Lessons for Making Change Happen in Your Organization and Beyond , a guide for leaders to face their fears, transcend discord and polarization, and drive positive systemic and societal change. Dr. Harrison received his undergraduate degree from Haverford College and his medical degree from Dartmouth Medical School. He completed a pediatric residency and pediatric critical care fellowship at Intermountain’s Primary Children’s Hospital, and earned a Master of Medical Management at Carnegie Mellon University. He is an all-American triathlete, and represented the U.S. at the 2014 World Championships. He is also a two-time cancer survivor and nine-time Ironman participant. He is a loving husband and proud father of three adult children.

Sachin H. Jain, MD is CEO of SCAN Group and SCAN Health Plan, one of the nation’s largest not-for-profit Medicare Advantage plans, which serves more than 285,000 members across California, Nevada, Arizona and Texas. In late 2022, SCAN announced its intent to combine with CareOregon to form the HealthRight Group, with Jain as CEO of the new entity pending regulatory approval. Since Jain joined SCAN in 2020, SCAN has maintained its 4.5 STAR rating for the sixth year in a row, launched a range of new products—including the first ever LGBTQ+ health plan product—and expanded its operations into three Southwestern states. SCAN has also launched four subsidiary medical groups intended to support seniors through the full range of inflection points in the aging process. In less than three years, SCAN’s total revenues have grown by more than $1.2B. From 2015-2020, Jain was President and CEO of CareMore Health and Aspire Health, innovative care delivery systems with more than $1.6B in revenues, which serve 200,000 Medicare and Medicaid patients in 32 states. He also served as Chief Medical Information & Innovation Officer at Merck & Co. and was Senior Advisor to the Administrator of the Centers for Medicare & Medicaid Services (CMS). Jain was the first Acting Deputy Director for policy and programs at the Center for Medicare and Medicaid Innovation (CMMI). He graduated magna cum laude from Harvard College with a BA in government and earned his MD from Harvard Medical School and MBA from Harvard Business School. Jain is Adjunct Professor at the Stanford University School of Medicine. A widely read Forbes columnist, he has been recognized by Modern Healthcare as one of the “100 Most Influential People in US Healthcare.” LinkedIn named him its top voice for healthcare industry-related content.

Ellen Kelsay is president and CEO of Business Group on Health. She is a sought-after speaker and expert, including delivering Congressional testimony, Kelsay hosts the Business Group on Health podcast and has authored various industry publications including an article in Harvard Business Review on health equity and an op-ed in Modern Healthcare on value purchasing. She has been recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare. Business Group on Health is the largest non-profit organization devoted exclusively to representing large employers' perspectives on critical health, well-being and workforce strategy issues. The Business Group keeps its membership on the leading edge of innovation, thinking and action to address the delivery, financing, affordability and experience with the health care system. Leveraging its network of members and industry thought leaders, the Business Group drives change by sharing best practices, shaping health care policy and crafting innovative solutions to improve employee health and well-being and optimize business performance. Business Group members, many of whom have operations globally, include 64 Fortune 100 companies and over 450 companies in total who provide health coverage and well-being solutions for more than 60 million employees, retirees and their families in over 200 countries.

Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company changing the way the world treats weight with a new standard of care for obesity treatment. Kenyon built Calibrate with the belief that medication is a tool—not a long-term treatment—and that patients deserve alignment between providers and payors to ensure that the right patients receive the right medications for the right amount of time with the right programs wrapped around them. Calibrate's proprietary intensive lifestyle intervention has three years of proven and published results to improve both weight and overall metabolic health, and our continuous authorization puts payors back in control of access by taking risk on cost-effective care across a population. Calibrate has raised $150M and is backed by investors including Founders Fund, Tiger Global, Threshold, Forerunner, and Redesign Health, and was recognized as a World Economic Forum Technology Pioneer in 2021 and by Fast Company’s World Changing Ideas, TIME's Best Inventions, and the Employer Health Innovation Roundtable Traction Awards in 2022. Prior to Calibrate, Kenyon led business operations, growth, and strategic partnerships & communications at Capsule, a technology business rebuilding the pharmacy from the inside out. Before Capsule, she worked at beloved consumer brands in London and New York. Isabelle began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania. She was selected to the Forbes 30 Under 30 list in 2015. Isabelle additionally serves as the Advocacy Chair for Success Academy Charter School’s Young Professionals Committee.

Bio coming soon!

Arif Khan serves as Vice President, Enterprise Strategy at BlueCross BlueShield of North Carolina. He is responsible for strategic planning and intelligence, portfolio management, enterprise consulting, and corporate planning. He joined BCBSNC in May 2021 to serve as Vice President, Pharmacy Services and oversaw all aspects of corporate pharmacy, including formulary, networks, operations, specialty management, and pharmacy strategy and innovations. Khan is a high-performing health care executive with expertise across the health care continuum, including pharmacy, telehealth and digital engagement, wellness and disease management, care coordination, market-facing sales, and affordability and trend initiatives for health plans. Prior to joining BCBSNC, he spent his time in management and strategy consulting, helping launch a firm in Washington, D.C., followed by eight years at CareFirst BlueCross BlueShield as Vice President of Clinical Programs and Evaluation. He served on various board appointments, including for Baltimore Medical System, the National Alliance on Mental Illness (Metro Baltimore), the American Heart Association (Greater Maryland), and the Our Three Winners Foundation. Khan is a graduate of the University of North Carolina at Chapel Hill and has been recognized with the Maryland Chamber of Commerce’s Rising Star Award, the Daily Record’s “Successful by 40” VIP List, and the Baltimore Business Journal’s 40 under 40 award.

Bio coming soon!

Anjalee Khemlani is an award-winning journalist and senior reporter at Yahoo! Finance. Her role includes live reports and articles covering all things health care including digital health, insurance, health services and life sciences. Prior to Yahoo! Finance, Khemlani worked for a variety of regional and international news outlets covering breaking news, health care, business, DEI and politics.

Bio coming soon!

Bio coming soon!

Kevin Kumler is the President at Virta Health. Kumler grew up in a healthcare family and brings over 20 years of experience in the business of healthcare. Named an “Up & Comer” by Modern Healthcare in 2017, he has spent the past decade focused on advancing healthcare through digital innovations. His passion for Virta’s mission is a personal one, having lost his father to complications from Type 2 diabetes in 2020. Prior to joining Virta, Kumler served as President at Quartet Health (getting people access to the mental healthcare they need) and for over six years at Zocdoc, helping increase access to care for patients across the United States. Before joining Zocdoc, Kevin was an Associate Principal in McKinsey & Company’s Healthcare practice, where he spent ten years advising insurance companies, large health systems, and government organizations in the US, UK, and India. Kumler has an MBA from Stanford University and a BA in Mathematics-Economics from Wesleyan University in Connecticut. He lives in New Jersey with his wife, who is a Licensed Clinical Social Worker and Professor of Social work, and their three highly energetic children.

Bio coming soon!

At Bristol Myers Squibb (BMS), Chris Mancill leads the company's Worldwide Value Access and Payment (VAP) and Health Economics and Outcomes Search (HEOR) function, which is focused on defining and articulating the value of the BMS portfolio to payers and other access stakeholders around the globe and developing innovative solutions to help ensure appropriate patient access. Immediately before moving into his current role, he led the VAP function at BMS in the United States. Mancill has over 25 years of experience in access, pricing, government affairs, and reimbursement at the global and U.S. levels and has held leadership roles at the global and market levels at small to large biopharmaceutical companies, including Amgen, Merck KGaA, and MorphoSys. In addition to his responsibilities at BMS, Mancill is a Member of the Board of Directors at the National Pharmaceutical Council.

Bio coming soon!

Bio coming soon!

Tanvi Patel leads the Partner Services team at Amazon Pharmacy, where she is responsible for developing strategic relationships with payers, PBMs, employers, manufacturers, prescribers, suppliers, and tech enablers, in addition to building the underlying solutions that power and scale these partnerships. In this role, she is enabling Amazon Pharmacy to scale its vision of reimaging the pharmacy experience for patients and providers. During her 12-year tenure at Amazon, Patel has been the visionary for, and held leadership roles across, critical new initiatives at the intersection of consumer and digital innovation spanning consumer retail, devices, grocery, and fashion. Prior to joining Amazon, Patel spent a decade in in the mobile and media space as a strategy consultant and at MTV Networks. She holds BS degrees in Finance and Health Administration from University of Arizona, a MS in Information Technology from University of Maryland, and an MBA from New York University.

Bio coming soon!

Bio coming soon!

Bio coming soon!

Suchi Saria, is the Founder and CEO of Bayesian Health, the John C. Malone endowed chair and the Director of the Machine Learning (ML), AI and Healthcare Lab at Johns Hopkins University. Her research has pioneered the development of next generation diagnostic and treatment planning tools that use statistical machine learning methods to individualize care. She has written several of the seminal papers in the field of ML and its use for improving patient care. She has given over 250 invited keynotes and talks to organizations including the NAM, NAS, and NIH. Saria has served as an advisor to several Fortune 500 companies and her work has been funded by leading organizations including the NIH, FDA, NSF, DARPA and CDC. Saria has been featured in Bloomberg News and PBS NOVA, and she has won several awards for excellence in AI and care delivery, including IEEE’s “AI’s 10 to Watch”, Sloan Fellow, MIT Tech Review’s “35 Under 35”, National Academy of Medicine’s list of “Emerging Leaders in Health and Medicine”, World Economic Forum’s 100 Brilliant Minds Under 40, Rock Health’s “Top 50 in Digital Health”, Modern Healthcare's Top 25 Innovators, The Armstrong Award for Excellence in Quality and Safety and Society of Critical Care Medicine’s Annual Scientific Award.

Bio coming soon

Angela Shen, MD, MBA is currently Vice President of Strategic Innovation Leaders at Mass General Brigham (MGB) Innovation, and Head of Regulatory at MGB Gene and Cell Therapy Institute. Dr. Shen specializes in translational medicine, clinical development, and regulatory affairs. With over 18 years in the pharmaceutical industry, Dr. Shen has led oncology and rare disease programs through all stages of drug development. Dr. Shen has served as Chief Medical Officer (CMO) at biotech startups like Walking Fish, Arcellx, NKarta, Arvinas, and was acting CMO of Tizona. At Novartis, Dr. Shen was extensively involved with in-licensing University of Pennsylvania’s CAR-T technology. She assembled and led the clinical team responsible for designing and launching the industry’s first multi-site, registration CAR-T trial, which resulted in the approval of Kymriah® (CTL019, CART-19) for pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Dr. Shen earned her BS from Rensselaer’s accelerated biomedical program, MD from Albany Medical College in New York, and MBA from NYU Stern School of Business.

Ashley Smith is a Partner in Oliver Wyman’s Health and Life Sciences practice, based in San Francisco. She focuses on advising payers, health systems, pharmaceutical companies and retailers on forming unique partnerships to capture value in the changing healthcare market. Prior to Oliver Wyman, Smith was an associate in the Strategy and Corporate Development group at Mercer, the world’s leading provider of HR and related financial services, where she supported global business strategy, new offer development, merger, acquisition, and divestiture activities. In addition, she spent time at Booz & Company and Keefe, Bruyette & Woods. Smith received a BS in business administration, BA in economics (honors), and a BA in English literature from the University of California, Berkeley where she was also a member of Cal’s Pac-10 and NCAA-champion women’s rowing team.

Sarah is a Partner in Oliver Wyman’s Health & Life Sciences Practice based in the firm’s Philadelphia office. She works primarily with health insurers and at-risk provider organizations, typically in the government markets space (MA, D-SNP, Medicaid). She has experience in both US and Global markets. Prior to joining Oliver Wyman, Snider was a Director at a boutique healthcare management consultancy, where she worked primarily with insurers and pharmaceutical companies. She has a BS in Biological Engineering and M. Eng in Engineering Management, both from Cornell University.

Bio coming soon!

Bio coming soon!

Bio coming soon!

Susan Tousi is Chief Commercial Officer at Illumina, where she leads global sales, commercial operations, and commercial strategy. Tousi combines her extensive general management leadership and deep technical knowledge of Illumina’s product portfolio to ensure the global commercial success of the organization. Tousi has been with Illumina since 2012, and previously led the product development organization as Chief Product Officer. She has more than 25 years of R&D and business leadership at Fortune 100 technology companies and within the life sciences industry, including Kodak and Hewlett-Packard (HP). In 2022, Tousi was included in the Forbes 50 over 50: Entrepreneurs list, and in 2018, Tousi was elected to the National Academy of Engineers. Tousi was also named one of the 50 Top Diverse Leaders for 2020 by the California Diversity Council and is a member of the International Women’s Forum, a global organization of preeminent women of significant and diverse achievement. Tousi holds an MBA degree from UCLA and an Honors BS in Engineering Science and Mechanics from Pennsylvania State University. Tousi currently serves on the Scientific Advisory Board for Vizgen, as well as on the Board of Directors for BICO. She is an executive trustee at the La Jolla Playhouse and serves on the UCSD Jacobs School of Engineering Dean’s Council of Advisors.

Bio coming soon!

Sara Vaezy is Executive Vice President and Chief Strategy and Digital Officer for Providence where she is responsible for system strategy and digital innovation for the integrated delivery network (IDN) which includes 52 hospitals and 1,085 clinics and serves over 5 million unique patients. Vaezy brings deep experience to the organization in both digital and enterprise strategy development and leads system strategy, the ongoing development and evolution of Providence’s integrated strategic and financial plan and cross-collaboration of the Providence councils as Providence continues to advance toward and design the system of the future. Vaezy is the architect of the Providence digital innovation model upon with the Digital Innovation Group (DIG) was founded, resulting in company partnerships and incubation of technologies that deliver value for Providence as well as other health systems. The model has resulted in the commercialization of three incubated technologies into independent companies from within DIG—all of which are supporting Providence in delivering on its mission and vision of health for a better world. Her framework for building and maintaining deep organizational relationships with stakeholders across the industry has resulted in partnerships with over 150 health system digital and innovation teams, venture capital organizations, industry analysts and influencers, and digital health organizations. Before Providence, she was at The Chartis Group, a healthcare management consulting firm. Earlier in her career she worked at the intersection of health services research and health policy with the Office of Financial Management, the Office of the Insurance Commissioner, and the Health Care Authority in Washington State. Vaezy serves as an NCQA Board Director, as a member of inaugural class of the Frist Cressey Ventures Collective, a Harvard Executive Education Faculty Member, a Health Evolution Forum Fellow, World 50 Digital 50 member, a Forbes Business Council Member, and a board observer for DexCare. She has won numerous awards and has been recognized as a Business Insider 30 under 40 Transforming the Future of Healthcare (2019), Catholic Health Association Tomorrow’s Leader (2019), a Becker’s Rising Star in Health IT (2020), and a Becker’s Women to Watch in Health IT (2020 & 2022). She holds an MHA and an MPH in Health Policy from the University of Washington School of Public Health and BAs in Physics and Philosophy from the University of California, Berkeley.

Emily Young is President of the Tufts Medicine Integrated Network, a distinctively different Population Health enterprise, including 2,300 primary care and specialist physicians and advanced practice clinicians. Young brings over two decades of healthcare management to her role. Young is a strategic and results-oriented healthcare executive with a passion for innovation and physician collaboration. She brings a deep managed care knowledge. Before joining the Tufts Medicine Integrated Network as President, she served as Vice President of Population Health and Transformation for Circle Health/Lowell General Hospital. In that role, Young drove the organization’s continued transformation to a value-based care organization, maximized physician and provider performance as an accountable care organization, and led the population health strategy, including developing and strengthening the necessary infrastructure to ensure success across the organization’s full care continuum. She also led the Lowell General Physician Hospital Organization (PHO). Before joining Lowell General Hospital, she worked at Tufts Health Plan for eight years and Anthem Blue Cross Blue Shield of New Hampshire for five years. Young volunteers for several community-based organizations, including serving on the Board of Incompass Human Services. Young earned her Master’s of Business Administration from Bentley University and her Bachelor’s Degree in Health Management and Policy from the University of New Hampshire.

Rachel Zeldin is a partner in the Health and Life Sciences practice at Oliver Wyman. She has deep experience across the healthcare ecosystem, helping insurers, care delivery organizations, healthcare technology companies, and biopharma. She specializes in helping companies think through whom they want to be when they grow up and launching the (sometimes disruptive) businesses required to help achieve these goals. Zeldin is passionate about helping her clients advance quality, affordable healthcare in their communities through new products and partnerships and good old-fashioned management rigor with sustainable economics so that companies can deliver their mission long-term. In addition to her Oliver Wyman experience, Zeldin worked at Collective Health, a venture-backed health benefits startup. She is a chemist by training and received her Ph.D. in synthetic chemistry from the University of California, Berkeley, where her research focused on developing innovative transition metal-catalyzed organic reactions and synthesizing complex molecules under the guidance of Professor Dean Toste. She lives on the beach in San Francisco with her husband, daughter, black lab, and Karl the Fog.